Literature DB >> 20669029

Frontline ethical issues in pediatric clinical research: ethical and regulatory aspects of seven current bottlenecks in pediatric clinical research.

Wim Pinxten1, Herman Nys, Kris Dierickx.   

Abstract

In the course of the past decades, considerable effort has been expended on the ethical guidance and legal regulation of pediatric clinical trials in Europe. Nonetheless, the conduct of clinical research in the population of minors continues to generate myriad ethical and regulatory issues. This paper explores seven bottlenecks in the ethical guidance and legal regulation that currently govern pediatric clinical research: (1) the integration of research in therapy, (2) the education of clinicians, (3) the empowerment of families, (4) the harmonization of protocol review, (5) the assessment non-clinical research objectives, (6) the control of placebo use, and (7) the provision of fair incentives for pediatric research conduct. For all of these issues, a clear view on the way forward is largely lacking, either because these issues have not been discussed in depth to date or because the existing debates have failed to generate a generally supported consensus.

Mesh:

Substances:

Year:  2010        PMID: 20669029     DOI: 10.1007/s00431-010-1268-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  57 in total

1.  The ethical bureaucracy.

Authors:  Christopher Martyn
Journal:  QJM       Date:  2003-05

2.  Therapeutic misconception and the appreciation of risks in clinical trials.

Authors:  Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

3.  Research ethics review and the bureaucracy.

Authors:  Paul M McNeill
Journal:  Monash Bioeth Rev       Date:  2002-07

4.  Research ethics committees in Europe: implementing the directive, respecting diversity.

Authors:  A Hedgecoe; F Carvalho; P Lobmayer; F Raka
Journal:  J Med Ethics       Date:  2006-08       Impact factor: 2.903

5.  Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in children.

Authors:  S Conroy; C Newman; S Gudka
Journal:  Ann Oncol       Date:  2003-01       Impact factor: 32.976

6.  Patient recruitment--European perspective.

Authors:  K Hoppu
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

7.  How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Authors:  Seema Shah; Amy Whittle; Benjamin Wilfond; Gary Gensler; David Wendler
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

8.  Communication of randomization in childhood leukemia trials.

Authors:  Eric Kodish; Michelle Eder; Robert B Noll; Kathleen Ruccione; Beverly Lange; Anne Angiolillo; Rebecca Pentz; Stephen Zyzanski; Laura A Siminoff; Dennis Drotar
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Presenting research information to children: a tale of two methods.

Authors:  Alan R Tait; Terri Voepel-Lewis; Shobha Malviya
Journal:  Anesth Analg       Date:  2007-08       Impact factor: 5.108

10.  Variation among institutional review boards in evaluating the design of a multicenter randomized trial.

Authors:  A R Stark; J E Tyson; P L Hibberd
Journal:  J Perinatol       Date:  2009-10-01       Impact factor: 2.521

View more
  1 in total

1.  Functional MRI pain studies in children? Yes, we (s)can!

Authors:  Gerbrich E van den Bosch; Tonya White; Dick Tibboel; Monique van Dijk
Journal:  Pediatr Radiol       Date:  2013-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.